Lu Li
Stock Analyst at UBS
(2.11)
# 3,000
Out of 5,238 analysts
19
Total ratings
71.43%
Success rate
1.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Neutral | $330 → $375 | $355.13 | +5.60% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintains: Buy | $48 → $52 | $40.42 | +28.65% | 6 | May 6, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $30 → $17 | $10.80 | +57.41% | 5 | Apr 10, 2026 | |
| MYGN Myriad Genetics | Maintains: Neutral | $8 → $6 | $4.29 | +39.86% | 5 | Feb 24, 2026 | |
| FLGT Fulgent Genetics | Upgrades: Buy | $20 → $30 | $15.96 | +87.97% | 1 | Aug 5, 2025 |
Waters
May 6, 2026
Maintains: Neutral
Price Target: $330 → $375
Current: $355.13
Upside: +5.60%
Veracyte
May 6, 2026
Maintains: Buy
Price Target: $48 → $52
Current: $40.42
Upside: +28.65%
QuidelOrtho
Apr 10, 2026
Maintains: Neutral
Price Target: $30 → $17
Current: $10.80
Upside: +57.41%
Myriad Genetics
Feb 24, 2026
Maintains: Neutral
Price Target: $8 → $6
Current: $4.29
Upside: +39.86%
Fulgent Genetics
Aug 5, 2025
Upgrades: Buy
Price Target: $20 → $30
Current: $15.96
Upside: +87.97%